The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18
Open accessAbstract
A novel, constitutively expressed and secreted IL-18 binding protein (IL-18BP) neutralizes IL-18 and thereby suppresses the production of IFN-γ, resulting in reduced T-helper type 1 immune responses. In the present study, four human and two mouse isoforms, resulting from mRNA splicing and found in various cDNA libraries, were expressed, purified, and assessed for binding and neutralization of IL-18 biological activities. Human IL-18BP isoform a (IL-18BPa) exhibited the greatest affinity for IL-18 with a rapid on-rate, a slow off-rate, and a dissociation constant (Kd) of 399 pM. IL-18BPc shares the Ig domain of IL-18BPa except for the 29 C-terminal amino acids; the Kd of IL-18BPc is 10-fold less (2.94 nM). Nevertheless, IL-18BPa and IL-18BPc neutralize IL-18 >95% at a molar excess of two. IL-18BPb and IL-18BPd isoforms lack a complete Ig domain and lack the ability to bind or neutralize IL-18. Murine IL-18BPc and IL-18BPd isoforms, possessing the identical Ig domain, also neutralize >95% murine IL-18 at a molar excess of two. However, murine IL-18BPd, which shares a common C-terminal motif with human IL-18BPa, also neutralizes human IL-18. Molecular modeling identified a large mixed electrostatic and hydrophobic binding site in the Ig domain of IL-18BP, which could account for its high affinity binding to the ligand. It is likely that preferential secretion of functional and nonfunctional isoforms of IL-18BP affect the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessment of protein models with three-dimensional profiles
Lüthy, R., Bowie, J. U., & Eisenberg, D. (1992) · Nature · doi:10.1038/356083a0 · Cited by 3,525
pEF-BOS, a powerful mammalian expression vector
Mizushima, S., & Nagata, S. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.17.5322 · Cited by 1,605
Acquisition of lymphokine-producing phenotype by CD4+ T cells
Seder, R. A., & Paul, W. E. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003223 · Cited by 1,557
Defective NK Cell Activity and Th1 Response in IL-18–Deficient Mice
Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80543-9 · Cited by 911
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., & Wallach, D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.323 · Cited by 814
Interleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Self-citationYoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S., Okamura, H., Akira, S., & Nakanishi, K. (1998) · PubMed · Cited by 770
Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S.-I., Okamura, H., Akira, S., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3400 · Cited by 675
Puren, A. J., Fantuzzi, G., Gu, Y., Su, M. S., & Dinarello, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1379 · Cited by 545
Self-citationPurification and Characterization of the Human Interleukin-18 Receptor
Torigoe, K., Ushio, S., Okura, T., Kobayashi, S., Taniai, M., Kunikata, T., Murakami, T., Sanou, O., Kojima, H., Fujii, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25737 · Cited by 473
Efficient infection of monkey cells with DNA of simian virus 40.
Sompayrac, L. M., & Danna, K. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7575 · Cited by 391
Protein fold recognition using sequence‐derived predictions
Fischer, D., & Eisenberg, D. (1996) · Protein Science · doi:10.1002/pro.5560050516 · Cited by 301
Endotoxin-induced serum factor that stimulates gamma interferon production
Nakamura, K., Okamura, H., Wada, M., Nagata, K., & Tamura, T. (1989) · Infection and Immunity · doi:10.1128/iai.57.2.590-595.1989 · Cited by 299
A newly defined interleukin-1?
Bazan, J. F., Timans, J. C., & Kastelein, R. A. (1996) · Nature · doi:10.1038/379591a0 · Cited by 281
Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1β
Vigers, G. P. A., Anderson, L. J., Caffes, P., & Brandhuber, B. J. (1997) · Nature · doi:10.1038/386190a0 · Cited by 276
Arend, W. P., Malyak, M., Smith, M. F., Whisenand, T. D., Slack, J. L., Sims, J. E., Giri, J. G., & Dower, S. K. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4766 · Cited by 241
Parnet, P., Garka, K. E., Bonnert, T. P., Dower, S. K., & Sims, J. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.3967 · Cited by 223
IL-18 binding and inhibition of interferon γ induction by human poxvirus-encoded proteins
Xiang, Y., & Moss, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11537 · Cited by 200
Fantuzzi, G., Puren, A. J., Harding, M. W., Livingston, D. J., & Dinarello, C. A. (1998) · Blood · doi:10.1182/blood.v91.6.2118 · Cited by 196
Self-citationKüsters, S., Tiegs, G., Alexopoulou, L., Pasparakis, M., Douni, E., Künstle, G., Bluethmann, H., Wendel, A., Pfizenmaier, K., Kollias, G., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271119 · Cited by 176
Puren, A. J., Razeghi, P., Fantuzzi, G., & Dinarello, C. A. (1998) · The Journal of Infectious Diseases · doi:10.1086/314481 · Cited by 101
Self-citationMiki, T., Matsui, T., Heidaran, M. A., & Aaronson, S. A. (1989) · Gene · doi:10.1016/0378-1119(89)90411-3 · Cited by 66
Terlizzese, M., SIMONI, P., & Antonetti, F. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.1047 · Cited by 20
Cited by
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
“By Immunity 39, December 12, 2013 ª2013 Elsevier Inc. 1011 preventing the binding of the agonist to IL-18R, and neutralizing IL-18 activity, IL-18BP dampens IFN-g production and consequently limits Th1 cell responses (Kim et al., 2000; Novick et al., 1999) (Figure 4).”
Interleukin-18 Regulates Both Th1 and Th2 Responses
Nakanishi, K., Yoshimoto, T., Tsutsui, H., & Okamura, H. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.423 · Cited by 1,315
Interleukin-18 and IL-18 Binding Protein
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00289 · Cited by 938
“IL-18BP is a constitutively secreted protein, with an exceptionally high affinity for IL-18 (400 pM) (72) (Figure 1).”
BackgroundSelf-citationIL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Interleukin-18 Binding Protein
Novick, D., Kim, S.-H., Fantuzzi, G., Reznikov, L. L., Dinarello, C. A., & Rubinstein, M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80013-8 · Cited by 779
Self-citation
Metadata
- Authors
- Kim, S.-H., Eisenstein, M., Reznikov, L., Fantuzzi, G., Novick, D., Rubinstein, M., & Dinarello, C. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-02
- Volume
- 97
- Issue
- 3
- Pages
- 1190-1195
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1997884858
- Cited by
- 341
- References
- 23
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.